Evidence map›Paper›PMID 40347345›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2025

Analysis of Protein Glycation Inhibition Using Polyacrylamide Gel Electrophoresis.

Handunge Kumudu Irani Perera

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Handunge Kumudu Irani PereraDepartment of Biochemistry, Faculty of Medicine, University of Peradeniya, Peradeniya, Sri Lanka. kumudu.perera@med.pdn.ac.lk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nonenzymatic glycation of proteins proceeds over a period, generating harmful advanced glycation end products (AGEs). The accumulation of AGEs is accelerated with chronic hyperglycemia and aging and is implicated in the pathogenesis of chronic diabetic complications and age-related chronic diseases. Assessment of protein glycation requires expensive specialized equipment. The procedure described in this chapter is a simple electrophoresis-based technique that can be used to identify inhibitors of protein glycation. Polyacrylamide gel electrophoresis carried out under native conditions (Native PAGE) separates proteins according to their net charge, shape, and size. As glycation targets free amino groups of proteins, a change in the net charge of the protein occurs following glycation. Since the degree of change in the net charge is proportionate to the degree of glycation, Native PAGE can be used to assess potential inhibitors of protein glycation.

Indexed as

Electrophoresis, Polyacrylamide GelGlycation End Products, AdvancedProteinsGlycosylationHumansGlycation End Products, AdvancedProteinsInhibitorsNative PAGENet chargePolyacrylamide gelProtein glycation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.